Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin

Haematologica

Volumn 83, Issue 4, 1998, Pages 338-346

  Llamas, Pilar ^a,b   Cabrera, Rafael ^a   Gómez Arnau, Juan ^a   Fernández, Manuel Nicolas ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b NONE   (Spain)

Author keywords

Aprotinin; Blood requirements; Hemostasis; Orthotopic liver transplantation

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIPLASMIN; APROTININ; D DIMER; FRESH FROZEN PLASMA; PLASMIN; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LIVER PERFUSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; REPERFUSION; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; AGED; APROTININ; BLOOD COAGULATION; BLOOD TRANSFUSION; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SERINE PROTEINASE INHIBITORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 0031976844     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (first of two parts). N Engl J Med 1989; 321: 1012-22.
2. Maddrey WC, Van Thiel D. Liver transplantation: an overview. Hepatology 1982; 8:948-59.
3. Bontempo FA, Lewis JH, Van Thiel DH, et al. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 1985; 39:532-6.
4. Lewis JH, Bontempo FA, Awad SA, et al. Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology 1989; 9:710-4.
5. Cabrera R, Ríos E, Briz M, et al. Behavior of the coagulation and fibrinolysis during liver transplantation for liver cirrhosis. Transplantology 1992; 3:87-95.
6. Porte RJ. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Haemost 1993; 19:191-6.
7. Porte RJ, Bontempo FA, Knot EAR, Lewis JH, Kang YG, Starzl TE. Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation. Transplant Proc 1989; 21:3542.
8. Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 1988; 71:1090-5.
9. Arnoux D, Boutière B, Houvenaeghel M, Rousset-Rouvière A, Le Treut P, Sampol J. Intraoperative evolution of coagulation parameters and t-PA/PAI balance in orthotopic liver transplantation. Thromb Res 1989; 55:319-28.
10. Kang Y, Lewis JH, Navalgund A, et al. Epsilon-amino-caproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987; 66:766-73.
11. Kang Y. Coagulation and liver transplantation. Transplant Proc 1993; 25:2001-5.
12. Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Drug Res 1983; 33:479-94.
13. Royston D. High-dose aprotinin therapy: a review of the first five years experience. J Cardiothorac Anesthesiol 1992; 6:76-100.
14. Neuhaus P, Bechstein WO, Lefèbre B, Bumhardt C, Slama K. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 1989; ii:924-5.
15. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99:788-97.
16. Mallet SV, Cox D, Burroughs AK, Rolles K. Aprotinin and reduction of blood loss and liver requirements in orthotopic liver transplantation. Lancet 1990; 336: 381.
17. Mallet S, Rolles K, Cox D, Burroughs A, Hunt B. Intraoperative use of aprotinin (Trasylol®) in orthotopic liver transplantation. Transplant Proc 1991; 23:1931-2.
18. Hunt BJ, Cottam S, Segal H, Ginsburg R, Potter D. Inhibition by aprotinin of t-PA mediated fibrinolysis during orthotopic liver transplantation. Lancet 1990; 336:381.
19. Grosse H, Lobbes W, Frambach M, Von Broen O, Ringe B, Barthels M. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss. Thromb Res 1991; 63:287-97.
20. Grosse H, Lobbes W, Frambach M, Ringe B, Barthels M. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation. Semin Thromb Haemost 1993; 19:302-5.
21. Segal HC, Hunt BJ, Cottam S, et al. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin. Transplantation 1994; 58:1356-60.
22. Segal HC, Hunt BJ, Cottam S et al. Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Transplantation 1995; 59:366-70.
23. Cottam S, Hunt B, Segal H, Ginsburg R, Potter D. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation. Transplant Proc 1991; 23:1933.
24. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin. J Thorac Cardiovasc Surg 1989; 97:364-72.
25. Himmelreich G, Hundt K, Neuhaus P, Roissant R, Riess H. Decreased platelets aggregation after reperfusion in orthotopic liver transplantation. Transplantation 1992; 53:582-6.
26. Bertolino G, Locatelli A, Noris P, et al. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery. Haematologica 1996; 81:116-20.
27. Owen CA, Rettke SR, Bowie EJW, et al. Hemostatic evaluation of patients undergoing liver transplantation. Mayo Clin Proc 1987; 62:761-72.
28. De Smet AAEA, Joen MCN, van Oeveren W, et al. Increased anticoagulation during cardiopulmonary bypass by aprotinin. J Thorac Cardiovasc Surg 1990; 100:520-7.
29. Bellani KG, Estrin JA, Ascher NL, Najarian JS, Bushman J, Buckley JJ. Reperfusion coagulopathy during human liver transplantation. Transplant Proc 1987; 19:71-2.
30. Gerlach H, Rossaint R, Slama K, et al. No requirements for cryoprecipitate or platelet transfusion during liver transplantation. Transplant Proc 1993; 25: 1813-6.
31. Patrassi GM, Viero M, Sartori G, et al. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 1994; 34:507-11.
32. Groh J, Weite M, Azad SC, Forst H, Pratschke E, Kratzer MAA. Does aprotinin affect blood loss in liver transplantation? Lancet 1992; 340:173.
33. Welte M, Groh J, Azad S, Anthuber M, Haller M, Kratzer A. Effect of aprotinin on coagulation parameters in liver transplantation. Semin Thromb Haemost 1993; 19:297-9.
34. Ickx B, Pradier O, Degroote F, et al. Effect of two different dosages of aprotinin on perioperative blood loss during liver transplantation. Semin Thromb Haemost 1993; 19:300-1.
35. Soilleux H, Gillon MC, Mirand A, Daibes M, Leballe F, Ecoffey C. Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesthesiol Analg 1995; 80:349-52.
36. Monedero P, Páramo JA, Carrascosa F, et al. Reducción de los requerimientos de hemoderivados en el trasplante hepático con aprotinina. Rev Esp Anestesiol Reanim 1995; 42:82-6.
37. Böhrer H, Fleischer F, Lang J, Vahl C. Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. J Cardiothorac Anesthesiol 1990; 4:222-8.
38. Baubillier E, Cherqui D, Dominique C, et al. A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 1994; 57:1664-5.
39. Milroy SJ, Cottam S, Tan KC, Hilmi I, Oyesola B. Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. Br J Anaesthesiol 1995; 75:747-51.